The Middle EAST Central Pontine Myelinolysis Market was valued at USD 0.15 billion in 2024 and is projected to reach USD 0.30 billion by 2034, registering a CAGR of 7.5%. This growth trajectory is underpinned by increasing awareness of neurological disorders and advancements in diagnostic and therapeutic options. The rising incidence of conditions leading to central pontine myelinolysis, such...